In the new era of the strategic transformation of China's pharmaceutical industry from generics to a combination of generics and innovations, we pharmaceutical people have been given a greater mission and responsibility. Especially in the past two years, the international situation has been unprecedentedly severe and the business environment has been complex. Against the backdrop of multiple unexpected factors, the pharmaceutical industry has accelerated changes, intensified competition, and faced unprecedented challenges.
The wind is high and the waves are strong, it is the time to work hard. We firmly believe that working together is the key to breaking new ground and writing a new chapter. With reshuffle and reshaping becoming the main theme of the industry, only by using communication to break the "involution" and replacing the traditional competition model with the concept of win-win cooperation can we achieve a win-win situation.
Those who are determined to travel thousands of miles will stop at their feet if they fail to hit the right path. To this end, we will hold the 6th CMC-China at the Suzhou Expo Center on August 15-16, 2024. CMC-China takes R&D as the main line, connects the upstream and downstream of medicine, and uses the trust of circle friends as the link to help everyone "find the next partner." Since 2019, we have successfully held 5 sessions, and the brand influence has continued to increase. The fifth CMC-China Expo to be held in August 2023 has more than 10,000 registrations, nearly 8,000 participants, and nearly 300 companies participating in the exhibition, significantly increasing its scale and influence.
Those who do not plan for the overall situation cannot plan for one area. The 2024 CMC-China Expo will set up four pavilions B, C, D, and E, covering the themes of biopharmaceuticals, small molecule innovative drugs, MAH&CXO&DDS, and original and auxiliary packages, covering "antibodies, peptides & nucleic acids, cell and gene therapy, XDC, size More than 20 forums in the fields of molecular new drug innovation, clinical trials, MAH, inhaled preparations, transdermal preparations, traditional Chinese medicine innovation, generic drugs and improved new drugs, sustained and controlled release preparations/injections, original and auxiliary drugs, green pharmaceuticals, synthetic biology, etc. Hundreds of industry experts and industry elites will be invited to the event to discuss cutting-edge topics and development trends in the fields of biology, chemical pharmaceuticals and traditional Chinese medicine, share the latest results, experiences and strategic thinking, and better empower the development of China's pharmaceutical industry.
Keep moving forward with determination, no matter how far you are, you will reach it. We will continue to ride the wind and waves forward, using high-quality industrial data as the support, efficient personal network data as the link, and high-standard conferences as the driving force to help everyone better connect people, connect resources, explore cooperation opportunities, and help high-tech Quality growth and joint creation of sustainable value.
